Latest Profit Growth News

Microequities Asset Management Group Limited reported a 19.3% rise in net profit for FY25, driven by strong fund performance and a surge in performance fees, while declaring a fully franked final dividend of 2.0 cents per share.

Baby Bunting delivered a standout FY25 with pro forma NPAT soaring 228% to $12.1 million, driven by record sales and a successful store refurbishment program. The retailer’s growth strategy is gaining momentum as it plans an aggressive rollout of its ‘Store of the Future’ concept.

Cochlear Limited reported a solid FY25 with 4% revenue growth and a 1% rise in underlying profit, underpinned by new product launches and expanding evidence linking implants to reduced dementia risk. The company’s FY26 outlook signals further gains as it advances market leadership and innovation.

Cochlear Limited reported a 4% revenue rise in FY25, driven by strong implant sales and launched the world’s first smart cochlear implant system. The company forecasts up to 17% profit growth in FY26, underpinned by innovation and expanding markets.

Cochlear Limited has reported steady financial growth with a 4% rise in sales revenue and a 9% increase in underlying net profit for the fiscal year ending June 2025, maintaining its dividend payout.

HiTech Group has reported a solid 7.1% revenue increase for FY2025, driven by strong government sector demand for ICT talent and services, alongside a 10% rise in net profit after tax.

Servcorp Limited reported a landmark FY25 with revenue up 11% to $352.1 million and net profit after tax rising 36% to $53.1 million, driven by disciplined execution and strategic global expansion.

FSA Group Limited reported a robust 43% increase in net profit for FY2025, alongside a steady 3% rise in loan origination and a 14% expansion in loan pools. The company declared a fully franked final dividend of 3.5 cents per share, signaling confidence in its growth trajectory.

Pro Medicus Limited has delivered a record-breaking FY2025 with soaring profits and a wave of major US healthcare contracts, setting the stage for continued expansion.

Pro Medicus Limited has reported a robust FY25 with revenue climbing nearly 32% and net profit up 39%, prompting a significant dividend increase.

Viva Leisure Limited reported a strong financial performance for FY2025 with a 30% revenue increase and a 61% rise in net profit, yet chose not to declare dividends. The company’s audited results highlight growth amid cautious capital management.

ASX Limited reported a solid FY25 financial performance with a 7.5% rise in underlying net profit and a higher fully franked dividend, while advancing its CHESS replacement project amid ongoing regulatory scrutiny.